Benzinga · Mar 5, 2026
Canaccord Genuity Maintains Hold on Quantum-Si, Lowers Price Target to $1
Canaccord Genuity analyst Kyle Mikson maintains Quantum-Si (NASDAQ:QSI) with a Hold and lowers the price target from $1.5 to $1.
QS
NASDAQ · QSI
Quantum-Si incorporated
Healthcare · Biotechnology
$1.26
Up+$0.04 (+2.78%)
Updated Nov 3, 2026, 8:58 PM
SID Score
5.4/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 272.8M
- P/E ratio
- -2.41
- Dividend yield
- 0.00%
- 52-week range
- $0.69 – $1.81
- Volume
- 8.21M
- Avg. volume
- 11.82M
Price performance · QSI
QSI price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Nov 2, 2026
QSI closed at $1.26 after 21 trading sessions, down 1.56% for the selected period.
- Last close
- $1.26
- Period change
- -1.56%
- Period low
- $1.09
- Period high
- $1.75
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 2, 2026 | $1.49 | $1.50 | $1.23 | $1.26 | 8.21M |
| Oct 30, 2026 | $1.57 | $1.60 | $1.405 | $1.46 | 9.91M |
| Oct 29, 2026 | $1.681 | $1.81 | $1.66 | $1.75 | 8.84M |
| Oct 28, 2026 | $1.63 | $1.73 | $1.59 | $1.72 | 10.05M |
| Oct 27, 2026 | $1.50 | $1.75 | $1.495 | $1.65 | 16.53M |
| Oct 26, 2026 | $1.425 | $1.48 | $1.36 | $1.46 | 10.35M |
| Oct 23, 2026 | $1.155 | $1.42 | $1.15 | $1.40 | 11.46M |
| Oct 22, 2026 | $1.17 | $1.21 | $1.145 | $1.15 | 3.57M |
| Oct 21, 2026 | $1.16 | $1.23 | $1.16 | $1.23 | 3.42M |
| Oct 20, 2026 | $1.06 | $1.20 | $1.04 | $1.16 | 6.18M |
| Oct 19, 2026 | $1.145 | $1.15 | $1.01 | $1.09 | 8.71M |
| Oct 16, 2026 | $1.33 | $1.33 | $1.10 | $1.12 | 7.69M |
| Oct 15, 2026 | $1.35 | $1.39 | $1.24 | $1.31 | 9.27M |
| Oct 14, 2026 | $1.34 | $1.44 | $1.3301 | $1.39 | 5.36M |
| Oct 13, 2026 | $1.345 | $1.46 | $1.31 | $1.41 | 6.24M |
| Oct 12, 2026 | $1.475 | $1.475 | $1.34 | $1.36 | 10.36M |
| Oct 9, 2026 | $1.26 | $1.66 | $1.258 | $1.53 | 40.9M |
| Oct 8, 2026 | $1.29 | $1.30 | $1.20 | $1.22 | 5.85M |
| Oct 7, 2026 | $1.17 | $1.3099 | $1.09 | $1.28 | 8.04M |
| Oct 6, 2026 | $1.29 | $1.41 | $1.19 | $1.22 | 8.7M |
| Oct 5, 2026 | $1.525 | $1.53 | $1.2601 | $1.28 | 19.19M |
Latest QSI news
The latest Smart Investors Daily articles mentioning QSI.
Stock researchCompany · Overview
Company
Market Activity
Research & News
QSI research
Overview
Company profile and research snapshot.
Company profile
Quantum-Si Inc is a life sciences company focused on the development and commercialization of proteomics research tools. The company has designed and developed a hardware, consumable, and software solution to provide a solution for protein detection and analysis. It has developed a proprietary universal single-molecule detection platform that enables Next-Generation Protein Sequencing (NGPS), the ability to sequence proteins.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- $2.00
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Sep 29, 2026 | HC Wainwright & Co. | Buy | — |
| Mar 5, 2026 | Canaccord Genuity | Hold | — |
| Dec 22, 2025 | Canaccord Genuity | Hold | — |
| Oct 27, 2025 | Canaccord Genuity | Hold | — |
| Sep 9, 2025 | Canaccord Genuity | Hold | — |
News briefing
No generated briefing is available yet.
ChartMill · Mar 3, 2026
Quantum-Si (NASDAQ:QSI) Reports Q4 2025 Revenue Miss, Guides for Strategic Transition Year
Quantum-Si reports Q4 revenue miss, lowers 2026 outlook to focus on launching its next-generation Proteus protein analysis platform.
Benzinga · Mar 3, 2026
Quantum-Si Shares Slip After Q4 Revenue Miss
Here's a look at why Quantum-Si stock is slipping after Q4 earnings.
Benzinga · Mar 3, 2026
Quantum-Si Sees FY2026 Sales $1.000M vs $7.148M Est
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
